Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Third Time’s A Charm? Endo’s Injectable Testosterone Finally Ready For Advisory Cmte.

Mar 15 2013

• By Cathy Dombrowski

Related Content

Platforms, Payments, Pathways And Pfizer: Business News In Brief

Dec 07 2009

Safety Fears Dog Indevus’ Testosterone Drug

Jul 02 2008

Indevus Submits Data To FDA With New Dosing Regimen For Hypogonadism Candidate

Jan 22 2008

Endo Branches Out With $370M Indevus Acquisition

Jan 05 2009

Endo's Fortesta To Join Crowded Testosterone Treatment Market In Q1

Jan 03 2011

Indevus Submits Nebido For Hypogonadism

Aug 28 2007

Related Companies

Endo, Inc.

Bayer AG

Pfizer Inc.

Additional Topics

United States Advisory Committees BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window